Senti Biosciences Holdings SNTI Cash Flow Statement (2021-2026)

NASDAQ SNTI
$0.16 +0.02 (+11.81%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Senti Biosciences Holdings Quarterly Cash Flow Statement

Periods 22 quarters
Latest Jun 2026

Senti Biosciences Holdings reported cash from operations of -$14.25M and free cash flow of -$14.25M for the quarter ended Jun 2026, down 9.0% year over year. This cash flow statement covers 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-11.41M-10.90M-11.81M-11.55M-16.64M-58.21M-18.72M-18.70M-14.92M-71.06M-12.11M-11.20M-28.87M-0.60M-14.11M-14.73M-18.13M-14.44M-4.22M-12.75M
Depreciation and DepletionDep. & Depletion
0.20M0.26M0.24M0.30M0.40M0.45M0.47M0.80M1.35M0.99M0.98M0.97M0.95M0.94M0.93M0.91M0.90M0.89M0.69M0.67M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.20M0.26M0.24M0.30M0.40M0.45M0.47M0.80M1.35M0.99M0.98M0.97M0.95M0.94M0.93M0.91M0.90M0.89M0.69M0.67M
Share-based CompensationStock Comp.
0.63M0.74M0.66M9.23M2.29M4.22M3.76M3.43M0.41M2.06M1.26M-0.78M0.67M0.61M1.20M1.53M1.55M1.43M1.32M1.05M
Deferred Taxes
0.58M
Gains from Sales and DivestituresGains Divest
-0.01M-0.01M-0.01M0.00M0.01M21.86M-0.04M0.11M
Asset Writedowns and ImpairmentWritedown
0.01M0.01M0.01M0.00M25.69M0.26M0.30M5.10M
Other non-cash itemsOther Non-Cash
0.81M0.77M-10.17M0.10M-0.23M0.40M-0.15M0.48M0.48M-1.51M-6.88M-0.27M
Non-cash ItemsNon-Cash Items
-5.63M2.31M-2.31M-1.63M-2.39M
Change in Working Capital
1.53M0.02M-0.17M0.02M-0.53M-0.45M0.44M0.06M0.33M0.68M-0.36M
Change in ReceivablesChange Receivables
0.05M-0.05M0.14M0.27M-0.23M0.14M-0.20M2.16M-1.16M-0.06M0.13M0.02M0.62M0.41M1.47M-1.95M-0.15M-0.83M-0.21M
Change in Account PayablesChange Payables
0.81M-2.33M-0.16M0.40M-0.14M0.09M0.28M0.61M-0.42M-0.76M0.39M-0.44M-0.39M1.24M0.36M-0.54M0.75M1.17M-1.89M1.22M
Change in Accrued ExpensesChange Accrued Exp.
1.77M0.16M-1.41M1.62M1.29M0.57M-1.85M-0.24M0.89M1.91M-2.95M-0.17M0.42M2.03M-1.12M-0.05M1.48M0.25M-0.32M-0.95M
Change in Other Operating AssetsOther Assets Change
0.06M0.38M0.99M0.47M-0.54M0.40M-0.40M-1.45M-3.35M-0.48M-0.50M-0.52M-0.52M-0.54M-0.56M-0.58M-0.61M-0.45M-0.58M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.68M-0.56M1.97M4.98M2.48M3.67M0.49M-0.09M-1.09M0.37M-0.95M-0.98M-0.92M-1.18M-1.09M-1.13M-1.19M-1.19M0.17M-2.92M
Other Working Capital ChangesOther WC Changes
-0.68M-0.62M1.59M3.98M2.02M4.20M0.09M0.31M0.36M3.72M-0.47M-0.49M-0.40M-0.66M-0.61M-0.58M0.06M-0.16M
Other Operating Activities (as filed)
-0.01M-0.03M0.03M-0.02M0.06M0.04M-0.04M0.01M0.11M0.04M0.05M0.00M
Cash from OperationsCash from Ops.
-8.81M-11.97M-10.06M-5.70M-10.14M-9.01M-16.30M-13.68M-15.38M-7.04M-11.68M-8.35M-7.87M-13.50M-14.05M-13.07M-9.45M-6.88M-7.48M-14.25M
Investing Activities
Capital ExpendituresCapex
0.93M3.99M7.38M11.26M14.20M8.53M6.51M3.67M1.86M0.00M0.02M0.01M0.20M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.11M0.06M0.01M0.11M
Change in Property, Plant and EquipmentChange in PP&E
-0.93M-3.99M-7.38M-11.26M-14.20M-8.53M-6.51M-3.67M-1.86M0.10M-0.02M0.06M-0.01M-0.18M0.11M
Purchase of InvestmentsInvestments Purchased
40.59M17.99M
Sale and Maturity of InvestmentsInvestments Sold
15.00M22.00M23.00M
Other Investing Activities (as filed)Other investing (as filed)
1.73M3.26M0.04M0.07M3.55M-0.22M3.06M-2.88M4.03M3.55M0.02M-0.02M
Cash from Investing ActivitiesCash from Investing
-0.93M-3.99M-7.38M-11.26M-14.20M-49.12M-9.50M18.33M21.14M0.10M-0.02M0.06M-0.01M-0.18M0.11M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
0.04M0.03M0.02M0.02M
Net Long-Term Debt Issued (Repaid)Net LT Debt
-0.04M-0.03M-0.02M-0.02M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.04M-0.03M-0.02M-0.02M
Change in Capital Stock
Common Stock IssuedStock Issued
0.01M0.02M0.14M112.85M-0.49M0.88M0.31M0.58M2.43M49.72M1.51M1.54M-0.53M0.53M
Net Shares Issued and RepurchasedNet Shares Issued
0.01M0.02M0.14M112.85M-0.49M0.88M0.31M0.58M2.43M49.72M1.51M1.54M-0.53M0.53M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
0.07M
Net Equity Issued and RepurchasedNet Equity Issued
0.01M0.02M0.14M112.85M-0.49M0.88M0.31M0.65M2.43M-8.19M1.51M1.54M-0.53M
Other financing activities (as filed)
-0.60M0.60M-0.23M-1.92M-0.53M-0.01M-0.12M-0.03M
Cash from Financing ActivitiesCash from Financing
0.49M0.02M-0.46M118.62M-0.49M0.88M-0.04M0.28M-0.02M0.56M2.44M51.29M-0.41M1.01M0.12M11.04M-0.12M9.68M
Additional items
Change in Cash
-9.25M-15.93M-17.89M101.66M-24.82M-57.25M-25.84M4.94M5.74M-6.38M-11.70M-8.35M-5.37M37.78M-14.46M-12.25M-9.32M4.17M-7.49M-4.57M
Ending Cash Balance
75.22M59.29M41.40M143.06M118.24M60.99M35.15M40.09M45.83M39.45M27.75M19.41M14.04M51.82M37.35M25.11M15.78M19.95M12.46M7.89M
Free Cash FlowFCF
-9.74M-15.96M-17.44M-16.96M-24.34M-17.54M-22.81M-17.34M-17.24M-7.04M-11.70M-8.35M-7.87M-13.52M-14.05M-13.27M-9.45M-6.88M-7.48M-14.25M
Net Cash FlowNCF
-9.25M-15.93M-17.89M101.66M-24.82M-57.25M-25.84M4.94M5.74M-6.38M-11.70M-8.35M-5.37M37.78M-14.46M-12.25M-9.32M4.17M-7.49M-4.57M

Senti Biosciences Holdings Cash Flow Statement API

Pull Senti Biosciences Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SNTI&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY